Alexion's Hantson poaches Biogen CFO Clancy as buzz of a looming pipeline shakeup heats up
You can count one more top exec at Biogen $BIIB out the exit as new CEO Michel Vounatsos builds his team at the big biotech. And the departing exec is headed straight to Alexion $ALXN, where Ludwig Hantson has been building his own team with an eye to stripping the pipeline ahead of a planned refurbishment.
This time the exec on the move is Paul Clancy, CFO at Biogen during the last eventful decade at the big biotech.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
